Molecular Templates : 10-K/A Filing FY 2022 : vimarsana.com

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 10-K/A




... | April 28, 2023

Related Keywords

France , Romania , Delaware , United States , San Francisco , California , Bucharest , Bucuresti , Texas , Menlo Park , Washington , Stanford University , Paris , France General , Colorado , French , American , Patrickg Enright , Kevinm Lalande , Davidr Hoffmann , Jasons Kim , Kevin Lalande , Markn Lampert , Jonathan Lanfear , Corsee Sanders , Eli Lilly , Harolde Barry Selick , David Hirsch , Joe Cunningham , Zimmer Biomet , Erice Poma , Gabriela Gruia , Harolde Selick , Scott Morenstein , Rogerj Waltzman , Lumos Pharma , Clinical Development , Company On , Permissible Services Of Independent Public Accountant , University Of Colorado , Biotechnology Value Fund , Name Of Each Exchange , Napo Pharmaceuticals Inc , Harvard Medical School , Wharton School , Company Certificate Of Designation Preferences , Exchange Act Person , Jaguar Health Inc , Principal At Lanfear Advisors , Juno Therapeutic Development Organization , Partners Os Ltd , Trading Fund , Artham Therapeutics Inc , Amunixpharmaceuticals Inc , Ichnos Sciences , Hoffmann Associates , Molecular Templates Inc , Wharton Doctoral Program , Regulatory Sciences , Holding Corporation , Poseida Therapeutics Inc , Compensation Committee , Johns Hopkins University Our Board , Collegium Pharmaceutical Inc , Company Board , Inspirna Inc , Hibercell Inc , Corporate Governance Committee , Astellas Pharma Us Inc , Procedures For Related Party Transactions , Brigham Young University , Wesleyan University , Theranostics Inc , Takeda Pharmaceuticals , University Of California , Business Administration , Development Operations , Rgenix Inc , Securities Exchange , Tessa Therapeutics Ltd , Nasdaq , University Of Pennsylvania , Beigene Ltd , Legend Biotech Corporation , Imclone Systems Inc , Novartis Pharmaceuticals Corporation , Damon Runyon Walter Winchell Cancer Fund , Rd Business Development , Brown University School Of Medicine , Member Of The Audit Committee , Audit Committee Our , Rapid Micro Biosystems Inc , Harvard Business School , American Cancer Society Senior , Exchange Act Person The Subject , Ultragenyx Pharmaceuticals Inc , Annex Services , Audit Committee , Board Or Committee , Stage Portfolio Committee , Health Venturesi Annex Fund , University Of Michigan Ann Arbor , Regulation Sk Our Audit Committee , Longitude Capital Partners , University Of Pennsylvania Our Board , Exchange Commission , Office Of The Celgene , Bucharest Medical School , Aquinnah Pharmaceuticals , Massachusetts Institute Of Technology , Brown University , Columbia Business School , University Of The Philippines , Rene Huguenin Curie Institute Cancer Center , Amunix Pharmaceuticals , Auditor Firm , Principal Of Gabriela Gruia Consulting , Health Ventures , Board Of Trustees , Business Development , Global Development Group Of Bristol Myers Squibb , Member Of The Compensation Committee , Audit Committee Pre , Pharmaceuticals Inc , University Of North Carolina At Chapel Hill , Celgene Organization , York University Our Board , Your Audit Committee , Tricida Inc , Management Services , Rene Descartes University , Ernst Young , Washington University St , Mark One , Zip Code , Exchange Act , Each Exchange , Value Per Share , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Nasdaq Global Select Market , Common Stock , Annual Report , Molecular Templates , Private Molecular , Private Securities Litigation Reform Act , Shiga Like Toxin , Executive Officer , Chief Scientific Officer , Chief Executive Officer , Vice President , North Carolina , Chapel Hill , New York University Our Board , Vice Chancellor , Pre Merger Threshold , Catalyst Biosciences , Protagonist Therapeutics , Damon Runyon Walter Winchell Cancer Fund Fellow , American Cancer Society Senior Fellow , Chief Executive , Gabriela Gruia Consulting , Chief Development Officer , Clinical Operations , Clinical Pharmacology , From August , Senior Vice President , Global Head , Regulatory Affairs , Novartis Oncology , Tessa Therapeutics , Breast Pathology , Curie Institute Cancer Center , Venture Partner , Longitude Capital , Poseida Therapeutics , Rapid Micro Biosystems , Collegium Pharmaceutical , Massachusetts Institute , Managing Member , Computer Engineering , Highest Distinction , Artificial Intelligence , Lanfear Advisors , Chief Operating Officer , Chemical Engineering , Ann Arbor , Washington University , Strategic Advisor , Global Development Group , Bristol Myers , Celgene Chief Medical Officer , Chief Medical Officer , Juno Therapeutics Executive Committee , Roche Late Stage Portfolio Committee , Roche Late Stage Clinical Operations , Fred Hutchinson Cancer Research , Ultragenyx Pharmaceuticals , Legend Biotech ,